Table S6 from Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis
Abstract
GSEA results for control- or GC-treated 20967 melanomas for the CD8, neutrophil and monocyte clusters related to Fig. 3.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
TGF-β signaling in diseases
Cancer
Stress
Anesthesia
and Immune Response
Publication details
- Publication date
- 9 February 2026
- Language
- EN